PlainRecalls
FDA Drug Moderate Class II Terminated

Docetaxel Injection USP, 20 mg/mL, One-Vial Formulation, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Visakhapatnam - 530 046 INDIA, NDC 43598-611-11

Reported: January 17, 2018 Initiated: January 9, 2017 #D-0213-2018

Product Description

Docetaxel Injection USP, 20 mg/mL, One-Vial Formulation, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Visakhapatnam - 530 046 INDIA, NDC 43598-611-11

Reason for Recall

Defective Container: Product complaints received of defect in the seal of the Docetaxel injection vials that the aluminum seal and/or stopper is removed when the cap is flipped off.

Details

Units Affected
1,051 vials
Distribution
Distributed nationwide in the USA, Uzbekistan, and Myanmar
Location
Princeton, NJ

Frequently Asked Questions

What product was recalled?
Docetaxel Injection USP, 20 mg/mL, One-Vial Formulation, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Visakhapatnam - 530 046 INDIA, NDC 43598-611-11. Recalled by Dr. Reddy's Laboratories, Inc.. Units affected: 1,051 vials.
Why was this product recalled?
Defective Container: Product complaints received of defect in the seal of the Docetaxel injection vials that the aluminum seal and/or stopper is removed when the cap is flipped off.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 17, 2018. Severity: Moderate. Recall number: D-0213-2018.